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The proapoptotic members of the Bcl-2 family can be subdivided into members that contain 
several Bcl-2 homology (BH) domains and those that contain only the BH3 domain. 
Although it is known that BH3-only proteins and the multi-BH domain proteins, Bak and 
Bax, are essential for programmed cell death, the overlapping role of these two subgroups 
has not been examined in vivo. To investigate this, we generated Bak/Bim and Bax/Bim 
double deficient mice. We found that although Bax
 
 
 
/
 
 
 
Bim
 
 
 
/
 
 
 
, but not Bak
 
 
 
/
 
 
 
Bim
 
 
 
/
 
 
 
, mice 
display webbed hind and front paws and malocclusion of the incisors, both groups of mice 
present with dysregulated hematopoiesis. Combined loss of Bak and Bim or Bax and Bim 
causes defects in myeloid and B-lymphoid development that are more severe than those 
found in the single knock-out mice. Bak
 
 
 
/
 
 
 
Bim
 
 
 
/
 
 
 
 mice have a complement of thymocytes 
that resembles those in control mice, whereas Bax
 
 
 
/
 
 
 
Bim
 
 
 
/
 
 
 
 mice are more similar to Bim
 
 
 
/
 
 
 
 
mice. However, thymocytes isolated from Bak
 
 
 
/
 
 
 
Bim
 
 
 
/
 
 
 
 or Bax
 
 
 
/
 
 
 
Bim
 
 
 
/
 
 
 
 mice are markedly 
more resistant to apoptotic stimuli mediated by the intrinsic pathway as compared with 
thymocytes from single-knockout mice. These data suggest an essential overlapping role for 
Bak or Bax and Bim in the intrinsic apoptotic pathway.
 
Apoptosis in mammals proceeds through two
distinct pathways, an “extrinsic” pathway,
which transduces an apoptotic signal after the li-
gation of death receptors on the cell surface, and
an “intrinsic” pathway, in which mitochondria
play a critical role (1). The intrinsic pathway is
regulated by the Bcl-2 protein family, which are
divided into antiapoptotic (Bcl-2, Bcl-x
 
L
 
, Mcl-1,
A1/Bfl-1, Bcl-w) and proapoptotic (Bax, Bak,
Bok/Mtd, Bcl-G, Bfk, Bad, Bim/Bod, Bik/
Blk/Nbk, Bid, Hrk/DP5, Bmf, Noxa, Puma/
Bbc3) members (2). Bcl-2–related proteins con-
tain Bcl-2 homology (BH 1–4) domains, which
are critical for homodimer and heterodimer
formation between the family members (3).
Although the antiapoptotic Bcl-2–like proteins
contain all four (or in the case of Mcl-1 at least
two) BH domains, the proapoptotic Bcl-2–
related proteins can be subdivided into two cat-
egories: the multi-BH domain (BH1-3: e.g.,
Bax, Bak, Bok) and the BH3-only proteins
(e.g., Bad, Bim; reference 4). Many Bcl-2 family
members are localized to the mitochondrial
outer membrane (and certain other intracellular
membranes), suggesting that mitochondrial dys-
function is involved in apoptosis (2, 5, 6). Dur-
ing intrinsic apoptosis signaling, the integrity of
the outer mitochondrial membrane is lost, lead-
ing to the dissipation of the transmembrane
potential through the opening of mitochondrial
permeability transition pores (6), and release of
apoptogenic mitochondrial intermembrane pro-
teins, such as cytochrome c (7, 8). In the cyto-
plasm, cytochrome c binds to the adaptor protein
APAF-1 which causes aggregation and activation
of the initiator caspase-9. Caspase-9 activates the
effector caspases -3, -6 and -7 (9), which cause
the downstream degradative events in apoptosis
(10). Apoptosis signaling through the intrinsic
pathway can be inhibited by overexpression
of any of the Bcl-2–like prosurvival family
members (11–13) or by loss of both proapop-
totic multi-BH domain proteins, Bax and Bak
(14–17).
Loss of any one of the antiapoptotic Bcl-2
family members, Bcl-2, Bcl-x
 
L
 
, Mcl-1, or Bcl-w,
causes severe developmental abnormalities (18,
19). In contrast, mice lacking single proapop-
totic multi-BH domain proteins (Bax or Bak)
survive to birth and reach adulthood (4). Bax-
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deficient mice appear normal but have increased numbers of
sympathetic and motor neurons and developmental arrest in
spermatogenesis (20), whereas no developmental or apop-
totic defects have been reported in Bak
 
 
 
/
 
 
 
 mice (17). How-
ever, the combined loss of Bax and Bak has dramatic conse-
quences; most animals die in utero and the few mice that
survive to birth display overt developmental apoptotic de-
fects, and isolated cells from these mice are resistant to most,
perhaps all, intrinsic, and in certain circumstances also some
extrinsic, apoptotic stimuli (14–16, 21–25).
The proapoptotic BH3-only Bcl-2 family members are
essential for the initiation of intrinsic apoptosis signaling (26,
27). In contrast to the multi-BH domain proteins, Bax and
Bak, the BH3-only proteins display a restricted pattern of
expression and stimulus-specific activation; thus, mice lack-
ing a single BH3-only protein often show cell type– and ap-
optotic stimulus-specific defects in the intrinsic apoptotic
pathway (26). The BH3-only protein, Bim, displays an ex-
pression pattern that overlaps at least partially with Bak or
with Bax (28–30). Bim-deficient mice have defects in dele-
tion of autoreactive thymocytes and B cells (31–33) and the
shutdown of T lymphocyte immune responses (34, 35).
Cultured Bim-deficient lymphocytes and granulocytes are
resistant to apoptosis induced by growth factor deprivation
or by treatment with the calcium ionophore, ionomycin
(31–33, 36–38). The developmental defects that occur in
Bcl-2–deficient mice are prevented by concomitant loss of
Bim; even loss of a single allele abrogates fatal polycystic kid-
ney disease (39). The rescue of the defects caused by Bcl-2
deficiency is unique to Bim, because deletion of Bik/Blk/
Nbk, another BH3-only protein expressed in the kidney
and hemopoietic cells, has no effect (40). Moreover, loss of
Bax is insufficient to prevent polycystic kidney disease or
melanocyte death that occurs in the Bcl-2
 
 
 
/
 
 
 
 mice, and has
only a minor effect on the apoptotic defects in Bcl-2
 
 
 
/
 
 
 
lymphocytes (41).
To examine the possible functional overlap between Bak
and Bim or Bax and Bim, we generated mice that lack Bak
plus Bim or Bax plus Bim. Bax/Bim, but not Bak/Bim,
double KO (DKO) mice displayed webbed feet in hind and
front paws, indicative of a defect in this programmed cell
death during development. Additionally, the Bax/Bim
DKO mice on a mixed background, but not on a pure
C57BL/6 background, were runted and had malocclusions
of the incisors that ultimately caused premature death. The
hematopoietic system in Bak/Bim DKO or Bax/Bim DKO
mice was dysregulated substantially, and showed an abnor-
mal increase in the number of circulating leukocytes in pe-
ripheral blood and other defects in primary and peripheral
lymphoid tissues. Moreover, thymocytes isolated from Bak/
Bim DKO or Bax/Bim DKO mice were resistant to apopto-
sis induced by cytokine deprivation or treatment with eto-
poside. These data suggest that the defects in Bak/Bim DKO
or Bax/Bim DKO mice are mediated by a resistance to in-
trinsic apoptotic stimuli.
 
RESULTS
Bax/Bim DKO mice display a defect in deletion of 
interdigital tissue
 
To examine the overlapping actions of Bak and Bim or Bax
and Bim we intercrossed Bim
 
 
 
/
 
 
 
 mice with Bak
 
 
 
/
 
 
 
 or
Bax
 
 
 
/
 
 
 
 mice to yield progeny that lack Bak and Bim or Bax
and Bim. Bak/Bim and Bax/Bim DKO mice were born at
the expected Mendelian ratios from intercrosses of Bak
 
 
 
/
 
 
 
Bim
 
 
 
/
 
 
 
 or Bax
 
 
 
/
 
 
 
Bim
 
 
 
/
 
 
 
 mice (unpublished data). Similar
to Bak/Bax DKO mice (17), Bax/Bim DKO mice were
born with webbed hind and front paws (Fig. 1 A), indicative
of a failure to delete the interdigital tissue between the toes.
Bax
 
 
 
/
 
 
 
, Bim
 
 
 
/
 
 
 
, Bak
 
 
 
/
 
 
 
, Bax
 
 
 
/
 
 
 
Bim
 
 
 
/
 
 
 
, Bax
 
 
 
/
 
 
 
Bim
 
 
 
/
 
 
 
,
and Bak/Bim DKO mice did not exhibit such defects. Al-
though Bax/Bim DKO mice kept on a C57BL/6 back-
ground (both strains backcrossed to C57BL/6 for 
 
 
 
12 gen-
erations before inter-crossing) and Bax/Bim DKO with
some contribution from the 129Sv background (Bax mutant
mice backcrossed to C57BL/6 for only 6 generations before
intercrossing with the Bim
 
 
 
/
 
 
 
 mice) displayed defects in the
deletion of the interdigital tissue, only Bax/Bim DKO mice
with more 129Sv contribution exhibited a runted phenotype
(Fig. 1 B) and malocclusions of the incisors (Fig. 1 C), and
failed to survive past 28 d. The Bax/Bim DKO mice with
significant 129Sv background contribution were able to
grow normally and reach adulthood when their upper inci-
sors were trimmed on a regular basis and they were fed pow-
dered food. These data suggest that genes from the 129Sv
background exacerbate the Bax/Bim DKO phenotype. His-
tologic analysis of nonhematopoietic tissues revealed that
similar to Bax-deficient mice (20), the Bax/Bim DKO males
were infertile. Thus, Bax and Bim, but not Bak and Bim, act
synergistically to induce apoptosis in the interdigitating tissue
and to ensure proper incisor development.
Figure 1. Bax/Bim DKO mice display developmental defects. 
(A) Photograph showing webbed feet in a Bax/Bim DKO (C57BL/6 background) 
mouse which is not seen in a WT mouse. (B) Photograph of Bax/Bim DKO 
runted mouse (white on a mixed C57BL/6/129sv background) compared 
with age- and sex-matched Bax / Bim /  control (black) mouse. (C)
Photograph of Bax/Bim DKO mouse (white on a mixed C57BL/6/129sv 
background) showing deformed incisors. 
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Dysregulation of hematopoiesis in Bak/Bim DKO 
and Bax/Bim DKO mice
 
Although Bax and Bim are indispensable for the apoptosis
of interdigital tissue, but not for other developmentally
programmed cell deaths during mouse embryogenesis, the
overlapping role of Bak or Bax and Bim during hemato-
poiesis is unknown. The total number of bone marrow cells
in Bak/Bim or Bax/Bim DKO mice was comparable to
that found in WT, Bax
 
 
 
/
 
 
 
, or Bak
 
 
 
/
 
 
 
 mice (Table I).
Bim
 
 
 
/
 
 
 
 mice displayed a 31% (P 
 
 
 
 0.05), 47% (P 
 
 
 
0.001), and 36% (P 
 
 
 
 0.02) decrease in bone marrow cells
as compared with Bak/Bim DKO, Bax/Bim DKO, and
WT mice, respectively (Table I). The decrease in bone
marrow cells in Bim
 
 
 
/
 
 
 
 mice may be related to the ob-
served osteosclerosis (unpublished data; reference 42). In
contrast to bone marrow, Bak/Bim DKO mice and Bax/
Bim DKO mice exhibited a 3.7-fold (P 
 
 
 
 0.001) and 3.9-
fold increase (P 
 
 
 
 0.001), respectively, in peripheral blood
leukocytes as compared with WT mice (Table I). Bak/Bim
DKO (P 
 
 
 
 0.05) and Bax/Bim DKO (P 
 
 
 
 0.09) mice had
an elevated count of peripheral blood leukocytes as com-
pared with Bim
 
 
 
/
 
 
 
 mice. In support of a previous study
(36), we observed that Bim
 
 
 
/
 
 
 
 mice displayed a 2.7-fold
increase (P 
 
 
 
 0.0001) in peripheral blood leukocytes and a
marked decrease in platelets compared with WT mice.
Bak/Bim DKO or Bax/Bim DKO mice had an elevated
platelet number that was similar to WT mice (Table I) as
compared with Bim
 
 
 
/
 
 
 
 mice. There was a 36, 41, and 46%
increase in total splenocytes in Bak/Bim DKO, Bax/Bim
DKO, and Bim
 
 
 
/
 
 
 
 mice, respectively, compared with WT
mice (Table I). These data indicate that the development of
splenomegaly occurs early in Bak/Bim DKO, Bax/Bim
DKO, and Bim
 
 
 
/
 
 
 
 mice. In contrast to spleen, the Bak/
Bim DKO and Bax/Bim DKO mice had similar numbers
of thymocytes as compared with WT mice. However, the
Bak/Bim DKO mice had a twofold increase (P 
 
 
 
 0.05) in
the number of thymocytes as compared with Bim
 
 
 
/
 
 
 
 
 
mice.
Similar to a previous report (36), Bim
 
 
 
/
 
 
 
 mice showed a
30% decrease in thymocyte numbers as compared with WT
mice. These data document that combined defects in Bak
or Bax and Bim cause an overall dysregulation in hemato-
poietic development that is more severe than the defects
that are observed in Bak
 
 
 
/
 
 
 
, Bax
 
 
 
/
 
 
 
, and Bim
 
 
 
/
 
 
 
 mice.
 
Bak/Bim DKO and Bax/Bim DKO mice have abnormally 
decreased numbers of bone marrow myeloid precursors 
but markedly increased numbers of mature myeloid cells 
in the periphery
 
Because we observed defects in hematopoietic development
in Bak/Bim DKO and Bax/Bim DKO mice that seemed to
 
Table I.
 
Counts of bone marrow cells, peripheral blood leukocytes and platelets, splenocytes, and thymocytes
 
WT Bak
 
 
 
/
 
 
 
Bax
 
 
 
/
 
 
 
Bim
 
 
 
/
 
 
 
Bak/Bim DKO Bax/Bim DKO
 
BMC, 1 
 
 
 
 E7 1.4 
 
 
 
 0.1 0.9 
 
 
 
 0.1 1.2 
 
 
 
 0.2 0.9 
 
 
 
 0.1
 
a
 
1.3 
 
  0.1b 1.7   0.2b
WBC, 1   E7/ml 0.9   0.04 0.9   0.2 1.0   0.1 2.4   0.2a 3.2   0.3a,b 3.5   0.6a
Platelets, 1   E8/ml 7.4   0.3 12.4   0.8a 8.7   0.5a 5.4   0.3a 7.6   0.7b 7.6   0.5b
RBC, 1   E6/ml 9.7   0.1 10.1   0.2 9.7   0.2 9.1   0.1a 9.8   0.2 10.2   0.2
Splenocytes, 1   E7 7.1   0.9 9.0   0.7 8.0   0.9 12.9   1.1a 12.2   1.5a 11.7   2.0a
Thymocytes, 1   E7  7.1   1.5 11.9   1.4a 9.5   1.2a 4.3   1.0 8.6   1.5b 5.6   0.4
Quantitative analysis of total hematopoietic cellularity. Cell counts represent viable cells as determined by trypan blue exclusion. White blood cell (WBC), platelet, and red blood 
cell counts were obtained by an automated counter. All data are expressed as mean   SE of at least eight mice/genotype, which were compared by Student’s t test. 
aP   0.05 as compared with WT mice.
bP   0.05 as compared with Bim /  mice.
BMC, bone marrow cells.
Table II. Phenotypical analysis of peripheral blood leukocytes
1   E5/ml WT  Bak /  Bax /  Bim /  Bak/Bim DKO  Bax/Bim DKO 
n   24 n   13 n   15 n   25 n   8n    12
CD19  39.0   1.5 36.7   3.9 44.8   4.3 112.5   11.4a 177.0   22.8a,b 199.4   28.2a,b
CD3  20.3   0.9 19.8   1.4 22.5   1.7 58.6   4.1a 74.7   9.7a 67.5   10.4a
CD3 CD4  12.1   0.6 11.4   0.8 14.3   1.0 23.9   1.8a 31.3   3.8a 25.4   3.5a
CD3 CD8  7.2   0.4 7.7   0.6 7.0   0.6 25.2   1.7a 28.7   4.0a 26.2   3.7a
CD11b Gr-1 CD62L  3.0   0.2 2.1   0.2a 5.5   0.7a 8.0   0.8a 10.0   1.2a 16.0   3.5a,b
CD11b Gr-1 CD62L  2.4   0.2 1.6   0.2a 2.3   0.2 4.1   0.4a 6.7   1.2a 6.3   1.0a
CD11b Gr-1  5.4   0.6 3.7   0.6 4.5   0.5 9.8   1.6a 13.2   3.8 11.4   1.8a
Quantitative analysis of individual subsets of leukocytes in peripheral blood as determined by flow cytometry. All data are expressed as means   SE, which were compared by 
Student’s t test.
aP   0.05 as compared with WT mice.
bP   0.05 as compared with Bim /  mice.REQUIREMENT FOR BAK OR BAX AND BIM DURING DEVELOPMENT | Hutcheson et al. 1952
mirror those found in Bim /  mice, we sought to delineate
the specific effects of the combined loss of Bak and Bim or
Bax and Bim on the cellular subset composition of bone
marrow, peripheral blood, spleen, and thymus. In bone mar-
row, Bax/Bim DKO mice exhibited a marked decrease in
the total numbers of CD11b  bone marrow cells, which are
precursors of peripheral blood monocytes or neutrophils, as
compared with WT mice. In contrast, there were no differ-
ences in myeloid precursors in Bak/Bim DKO as compared
with WT mice. The loss of Bax in Bim-deficient mice re-
sulted in a 67% increase (P   0.05) in the CD11b Gr-1 
bone marrow cells as compared with Bim /  mice. These
numbers of CD11b Gr-1  bone marrow cells were equiva-
lent to WT levels. The combined loss of Bak and Bim was
able to rescue CD11b Gr-1  and CD11b Gr-1  popula-
tions of bone marrow cells as compared with Bim /  mice
to the levels found in WT mice. These data suggest that Bak
and Bax seem to be differentially required but share some
overlapping functions for maturation or survival of myeloid
subpopulations in bone marrow of mice deficient for Bim.
Because Bak/Bim DKO and Bax/Bim DKO mice pre-
sented with reduced numbers of myeloid precursors in bone
marrow, we examined blood and peripheral hematopoietic
tissues to determine the effect of Bak plus Bim or Bax plus
Bim deficiency on circulating monocytes and neutrophils.
Bak/Bim DKO mice and Bax/Bim DKO mice had a 3.3-
fold and 5.3-fold (P   0.003) increase in the number of res-
ident monocytes, respectively, as compared with WT mice.
Bax/Bim DKO mice also had a twofold increase (P   0.05)
in resident monocytes as compared with Bim /  mice.
Bax /  and Bim /  mice exhibited only a 1.8-fold (P  
0.003) and 2.7-fold (P   0.0001) increase in these cells, re-
spectively (Table II). Additionally, Bak/Bim DKO and Bax/
Bim DKO mice showed a 2.8-fold and 2.6-fold increase
(P   0.002) in inflammatory monocytes, respectively, com-
pared with WT mice (Table II). Bax /  mice had similar
numbers of inflammatory monocytes and Bim /  mice had a
1.7-fold increase (P   0.0007) in inflammatory monocytes
compared with WT mice (Table II). Moreover, Bak/Bim
DKO and Bax/Bim DKO mice displayed a 2.4-fold and
Table III. Phenotypical analysis of bone marrow cells
1   E6 cells WT Bak /  Bax /  Bim /  Bak/Bim DKO Bax/Bim DKO
n   18 n   12 n   13 n   14 n   8n    10
CD19  4.0   0.6 2.6   0.5 3.3   0.4 3.0   0.4 3.4   1.0 7.7   0.6a,b
CD11b Gr-1  2.1   0.3 1.5   0.1 1.8   0.2 1.5   0.2 1.9   0.2 2.5   0.2b
CD11b Gr-1  4.9   0.6 2.2   0.2a 4.4   0.6 2.9   0.5a 4.1   0.6 2.0   0.3a
Quantitative analysis of B cells and myeloid cells in bone marrow as determined by flow cytometry. All data are expressed as mean   SE, which were compared by Student’s t test.
aP   0.05 as compared with WT mice.
bP   0.05 as compared with Bim /  mice.
Figure 2. Bak/Bim DKO and Bax/Bim DKO have normal numbers of 
tissue macrophages (A, B) Bak/Bim DKO and Bax/Bim DKO mice contain 
similar numbers of macrophages in their liver. Representative photomicro-
graphs of F4/80-positive cells in the liver in WT (n   13), Bak /  (n   12), 
Bax /  (n   7), Bim /  (n   16), Bak/Bim DKO (n   3), and Bax/Bim DKO 
(n   7) mice. Values represent the mean   standard error. (C) Quantita-
tive analysis of F4/80-positive macrophages in the peritoneum. Peritoneal 
cells from WT (n   23), Bak /  (n   12), Bax /  (n   9), Bim /  (n  15), 
Bak/Bim DKO (n   4), and Bax/Bim DKO (n   8) mice were analyzed for 
F4/80 antigen expression. Values represent the mean   standard error, 
which were compared by Student’s t test.JEM VOL. 201, June 20, 2005 1953
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2.1-fold increase (P   0.008), respectively, in circulating
neutrophils, whereas Bim /  mice had a 1.7-fold increase (P
  0.02) in neutrophils compared with WT mice (36). These
data demonstrate a synergistic effect on accumulation of
monocytes and neutrophils by the combined loss of Bak or
Bax and Bim. Although Bax / , Bim / , Bak/Bim DKO,
and Bax/Bim DKO mice have increased circulating mono-
cytes, paradoxically, we did not observe an increase in mac-
rophages in tissues. WT, Bak / , Bax / , Bim / , Bak/Bim
DKO, and Bax/Bim DKO mice displayed an equivalent
complement of macrophages in liver (Fig. 2, A and B). Sim-
ilarly, in the peritoneum there was a decrease in the numbers
of F4/80-positive cells only in Bim /  mice (37%, P  
0.0005) as compared with WT mice (Fig. 2 C). These data
suggest that recruitment of monocytes to tissue and their dif-
ferentiation into a macrophage is independent of intrinsic
apoptotic pathway.
B lymphocytes are increased abnormally in Bak/Bim DKO and 
Bax/Bim DKO mice
Mice lacking Bim have defects in deletion of autoreactive B
cells (32); therefore, we examined the effect of deleting Bak
and Bim or Bax and Bim on B cell development. There was a
substantial increase in B lymphocytes in Bax/Bim DKO bone
marrow compared with WT, Bax / , Bak / , Bim / , or
Bak/Bim DKO mice (Table III). These data demonstrate that
the combined loss of Bax and Bim, but not Bak and Bim, al-
ters B lymphocyte homeostasis in bone marrow more severely
than loss of Bim alone. The B cell population increased 4.5-
fold (P   0.001) and 5.1-fold (P   0.001) in blood and 1.9-
fold (P   0.01) and 1.7-fold (P   0.02) in spleen within Bak/
Bim DKO and Bax/Bim DKO mice, respectively, as com-
pared with WT mice (Tables II and IV). Moreover, the com-
bined loss of Bak or Bax in Bim /  mice led to higher num-
bers of circulating B cells in peripheral blood as compared
Table IV. Phenotypical analysis of splenic leukocytes
1   E6 WT Bak /  Bax /  Bim /  Bak/Bim DKO Bax/Bim DKO
n   18 n   13 n   12 n   14 n   8n    9
CD19  33.1   3.1 32.9   3.1 34.6   2.3 54.5   5.6a 63.7   8.1a 57.3   8.7a
CD3  20.8   1.5 19.0   1.7 17.8   0.8 39.2   3.2a 26.6   3.9b 27.6   3.9b
CD3 CD4  11.8   0.9 8.8   0.9a 9.6   0.8 17.2   2.0a 11.4   1.3b 10.8   1.3b
CD3 CD8  5.9   0.6 6.1   0.8 5.1   0.5 13.6   1.8a 8.2   1.4b 8.8   1.1a,b
CD11b Gr-1 CD62L /  1.5   0.1 1.3   0.1 1.4   0.3 2.0   0.3 2.5   0.9 1.8   0.4
Quantitative analysis of lymphocytes and myeloid cells in spleen as determined by flow cytometry. All data are expressed as mean   SE, which were compared by Student’s t test. 
aP   0.05 as compared with WT mice.
bP   0.05 as compared with Bim /  mice.
Figure 3. Bax/Bim DKO mice display an altered CD4 8 /CD4 8  
T cell ratio resulting from abundant accumulation of mature CD4 8  
T cells. (A) Bak/Bim DKO and Bax/Bim DKO mice display a 1:1 CD4 8 /
CD4 8  T cell ratio in their spleen. Single-cell splenocyte suspensions 
were stained with the indicated antibodies and then analyzed by flow 
cytometry. Shown is a dot plot gated on the CD45 CD3  splenocytes. 
(B) Bax/Bim DKO and Bim /  mice exhibit reduced percentages and 
numbers of CD4 8  double positive thymocytes. Single-cell thymocyte 
suspensions were stained with the indicated antibodies and analyzed by 
flow cytometry.REQUIREMENT FOR BAK OR BAX AND BIM DURING DEVELOPMENT | Hutcheson et al. 1954
with Bim /  mice (Table II). Bim /  mice showed a 2.9-fold
(P   0.0001) and a 1.6-fold (P   0.003) increase in B cells in
blood and spleen, respectively, as compared with WT mice;
these data were consistent with previous reports (36). Because
deficiency in Bak and Bim or Bax and Bim led to increased B
cells in the periphery, these data suggest that loss of Bak or
Bax in Bim /  mice may prevent deletion of B cells leading
to their abnormal accumulation in tissues.
Bim is essential for proper homeostasis of T lymphocytes
Deficiency in Bax (20) or Bim (36) were shown to affect the
development of T lymphocytes. Bak/Bim DKO, Bax/Bim
DKO, and Bim /  mice exhibited a 3.7-fold, 3.4-fold (P  
0.002), and 2.9-fold (P   0.0001) increase in T cells circulat-
ing in blood, respectively, as compared with WT mice,
whereas Bak /  and Bax /  mice had normal numbers of T
cells (Table II). In peripheral blood and in spleen, the
CD4 8 /CD4 8  T cell ratio was altered in Bak/Bim DKO
and Bax/Bim DKO mice. Bak/Bim DKO and Bax/Bim
DKO mice displayed an  1:1 CD4 8 /CD4 8  ratio (Fig.
3 and Tables II and IV), whereas WT mice showed a ratio of
 2:1. These data indicate that the change in the ratio of
CD4 8 /CD4 8  T cells may be due to the increased num-
bers of CD8 T cells in Bak/Bim DKO, Bax/Bim DKO, and
Bim /  animals (38). Although previously unreported, Bak / 
mice had a reduced CD4 8 /CD4 8  ratio in blood and
spleen. Similar to previous studies, Bim /  mice exhibited a
1.8-fold increase (36), whereas Bak/Bim DKO and Bax/Bim
DKO mice had only a marginal increase in splenic T cells as
compared with WT mice (Table IV). Bak/Bim DKO and
Bax/Bim DKO mice had fewer CD4  and CD8  T cells in
spleen as compared with Bim /  mice (Table IV).
Because Bak/Bim and Bax/Bim DKO mice displayed an
altered CD4 8 /CD4 8  T cell ratio similar to that found
in Bim /  mice, the thymus was examined to determine the
effect of deleting Bak and Bim or Bax and Bim on thymic
cell subset composition. Bak/Bim DKO mice displayed a
different thymic profile as compared with Bax/Bim DKO or
Bim /  mice. Bak/Bim DKO mice had elevated double-
negative population (CD4 CD8 ) as compared with WT,
Bim / , and Bax/Bim DKO mice. Although Bax/Bim
DKO and Bim /  mice showed a similar decrease in CD4 
CD8  thymocyte numbers, Bak/Bim DKO CD4 CD8 
thymocytes were equivalent in number to WT mice (Table
V). Moreover, Bak/Bim DKO mice had more CD4 CD8 
thymocytes as compared with WT, Bim / , and Bax/Bim
DKO mice. These data suggest that the accelerated matura-
tion of thymocytes that occurs in mice deficient for Bim re-
quires Bak, but not Bax.
Bak/Bim DKO and Bax/Bim DKO thymocytes are resistant to 
intrinsic apoptotic stimuli
Previous studies demonstrated that Bim-deficient thymo-
cytes are abnormally resistant to certain apoptotic stimuli,
such as cytokine withdrawal or treatment with the calcium
ionophore, ionomycin (36). Deficiency in Bax and Bim sub-
stantially reduced the loss of mitochondrial membrane po-
tential in response to cytokine deprivation or treatment with
etoposide as compared with WT, Bax / , Bim / , Bak / ,
and Bak/Bim DKO cells (Fig. 4 A). However, Bak/Bim
DKO and Bax/Bim DKO thymocytes displayed more
Rh123-posivity as compared with WT, Bak / , Bax / ,
and Bim /  mice (Fig. 4 A). A similar trend was observed in
Bax/Bim DKO and Bak/Bim DKO thymocytes that were
stained with annexin V or with 7-amino–actinomycin D
(7-AAD) after cytokine deprivation or treatment with etopo-
side (Fig. 4, B and C). Fewer Bax/Bim DKO and Bak/Bim
DKO thymocytes were stained with annexin V or 7-AAD as
compared with WT or single gene knock-out mice (Fig. 4,
B and C). Although treatment with an extrinsic apoptotic
stimulus, such as FasL, induced a similar staining pattern for
Rh123, annexin V, and 7-AAD in WT, Bax / , Bim / ,
Bak / , Bak/Bim DKO, and Bax/Bim DKO cells (Fig. 4,
A–C), Bak/Bim DKO and Bax/Bim DKO cells were
slightly more resistant to FasL-induced death. These data
demonstrate that Bak or Bax and Bim are required for thy-
mocyte apoptosis mediated by intrinsic death stimuli.
Because cytochrome C release generally occurs in cells
that undergo apoptosis through the intrinsic pathway (43),
and because caspase-9 requires cytochrome C to be acti-
vated (44, 45), we examined the activity of caspase-9 and
caspase-3 in cells from WT, Bak / , Bax / , Bim / ,
Bak/Bim DKO, and Bax/Bim DKO mice. There was
marked reduction ( 80%) in the activation of caspase-9
and -3 in Bak/Bim DKO and in Bax/Bim DKO cells as
compared with cells from all other genotypes (Fig. 4, D
Table V. Phenotypical analysis of thymocytes
1   E6 WT Bak /  Bax /  Bim /  Bak/Bim DKO  Bax/Bim DKO 
n   24 n   13 n   14 n   14 n   8 n   12
CD4 CD8  4.1   0.4 11.5   1.6a 7.4   0.5a 5.9   0.6a 11.0   2.0a,b 7.0   1.5
CD4 CD8  52.0   4.5 73.4   6.5a 65.1   4.8 19.3   2.2a 58.0   11.3b 19.8   4.3a
CD4 CD8  3.3   0.5 6.3   0.8a 4.7   0.4a 3.7   0.4 4.3   0.9 3.9   1.0
CD4 CD8  6.1   0.8 7.1   0.6 9.9   0.7a 7.3   0.7 12.9   2.0a,b 6.2   1.4
Quantitative analysis of thymocytes after analysis as determined by flow cytometry. All data are expressed as mean   SE, which were compared by Student’s t test.
aP   0.05 as compared with WT mice.
bP   0.05 as compared with Bim /  mice.JEM VOL. 201, June 20, 2005 1955
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and E). Deficiency in Bim resulted in a 54% reduction in
the activity of caspase-9 in cells cultured in serum alone
(cytokine deprivation), but had no effect on thymocytes
treated with etoposide (Fig. 4 D). However, at lower doses
of etoposide ( 2.5 ng/ml), Bim /  thymocytes had a
marked decrease in caspase-9 activity compared with WT
cells (unpublished data). Deficiency in Bim also resulted in
a 63 and 32% reduction in the activity of caspase-3 as com-
pared with WT cells after cytokine deprivation or treat-
ment with etoposide, respectively (Fig. 4 E). WT, Bak / ,
and Bax /  thymocytes displayed similar levels of activity
of caspase-9 and -3 after cytokine deprivation or treatment
with etoposide. These data further indicate that deficiency
in Bak and Bim or Bax and Bim reduces the activation of
caspases after an insult mediated by the intrinsic apoptotic
pathway (Fig. 4, D and E). Collectively, these data suggest
that the loss of Bim confers protection at the mitochondrial
membrane in a Bak- or Bax-dependent manner.
DISCUSSION
Members of the Bcl-2 protein family are essential for deter-
mining cellular survival/death after an apoptotic insult
through the intrinsic pathway (26). Loss of Bax or Bak alone,
two proapoptotic multi-BH-domain proteins, has relatively
little effect on mouse development, with the exception of
the male infertility found in Bax /  mice (17). Loss of BH3-
only genes results in increased cell accumulation and resis-
tance to apoptosis, which often is cell type– or stimulus-spe-
cific (46). For example, Bim is required for cytokine with-
drawal and calcium flux–induced apoptosis (36), whereas
Puma is essential for DNA damage–induced apoptosis trans-
duced via the tumor suppressor p53 (47, 48). The combined
loss of Bak and Bax has dramatic consequences for mouse
development and apoptosis signaling through the intrinsic
pathway (17). Although these data demonstrate the impact of
deleting two multi-BH domain proapoptotic Bcl-2 family
members, the consequences of removing a proapoptotic
multi-BH domain family member plus a BH3-only gene
have not been studied in vivo. To date, the only related
study examined the in vitro effect of deleting Bax and the
BH3-only protein, Noxa. Combined loss of Bax and Noxa
conferred upon cultured fibroblasts increased protection
against DNA damage–induced apoptosis as compared with
loss of either protein alone (49). However, there was no syn-
ergistic effect in Bax/Noxa DKO thymocytes that were UV
irradiated. These data suggest that Bax and Noxa interact
with each other in a cell type–specific manner. Here we
demonstrate that Bax/Bim DKO mice display webbed paws,
indicative of a developmental defect in apoptosis. A similar
defect was observed in Bak/Bax DKO mice (17), although
the role of Bim in the developing footpad of these mice was
not examined. However, Bak/Bim DKO mice were born
Figure 4. Bak/Bim DKO and Bax/Bim DKO thymocytes have abnor-
mally low sensitivity to intrinsic apoptotic stimuli. Thymocytes iso-
lated from WT, Bak / , Bax / , Bim / , Bak/Bim DKO, and Bax/Bim DKO 
mice were plated in triplicate and left untreated (death by cytokine depri-
vation) or were treated with etoposide (7.5 ng/ml) or FasL (20 ng/ml) and 
analyzed by flow cytometry. All data are expressed as percentages of (A) 
Rh123-positive, (B) annexin V-negative, or (C) 7AAD-negative cells nor-
malized to the 0 time point. Bak/Bim DKO and Bax/Bim DKO thymocytes 
display reduced activation of caspase-9 (D) and (E) caspase-3. Thymocytes 
isolated from WT, Bak / , Bax / , Bim / , Bak/Bim DKO, and Bax/Bim DKO 
mice were left untreated (cytokine deprivation) or were treated for 8 h 
with etoposide and then analyzed for the activity of caspase-9 and -3. 
Values represent the mean   standard error, which were compared by 
Student’s t test. *P   0.05 as compared with WT. All data are representa-
tive of two independently performed experiments. †P   0.05 as compared 
with Bim / .REQUIREMENT FOR BAK OR BAX AND BIM DURING DEVELOPMENT | Hutcheson et al. 1956
with normal digits. These data indicate that Bax and either
Bak or Bim are required for proper formation of the inter-
digital tissue. Moreover, these data suggest that in the ab-
sence of Bax and Bim, Bak and the remaining BH3-only
proteins are not sufficient for the induction of programmed
cell death in the developing footpad. However, in Bak/Bim
DKO mice, Bax must be activated by a BH3-only protein,
and this activation does not require the formation of higher-
order complexes of Bax and Bak. Taken together, these data
suggest that Bak and Bim may act at the same level in the de-
veloping footpad. Because BH3-only proteins function up-
stream of Bak/Bax in apoptosis signaling (15, 16, 27), this re-
sult indicates that Bim is the predominant activator upstream
of Bak in programmed cell death of interdigitating cells.
Bax/Bim DKO mice with increased contribution of
129Sv background genes displayed a more severe pheno-
type, including growth retardation, malocclusions of the in-
cisors, and premature death. Dramatic influence of genetic
background on the phenotype of mice lacking apoptosis-
regulatory genes was observed previously. For example, cas-
pase-3–deficient mice are embryonic lethal on a mixed
C57BL/6   129Sv background, but survive on an inbred
C57BL/6 background (50, 51). Thus, one has to be cautious
when interpreting small differences between KO and control
mice that are kept on a mixed genetic background. Our
work demonstrates clearly that Bax/Bim DKO mice display
a novel phenotype compared with Bax / , Bim / , or Bak/
Bax DKO mice; this indicates an overlapping function for
Bax and Bim in the development of teeth.
Few studies have examined the role of the Bcl-2 protein
family in the development of myeloid cells. A recent study
(37) demonstrated that cultured granulocytes lacking Bim or
overexpressing prosurvival Bcl-2 are resistant to cytokine
withdrawal in culture. Our data suggest that the proapop-
totic genes Bak and Bax are differentially required for mye-
loid progenitor cell survival/differentiation in the bone mar-
row of Bim /  mice. Even though Bim is a proapoptotic
gene, Bim /  mice have normal myeloid progenitor poten-
tial (unpublished data), but they have an unexpected reduc-
tion in total numbers of CD11b Gr-1  and CD11b Gr-1 
bone marrow cells. Bax, but not Bak, deficiency in Bim / 
mice is able to restore normal numbers of CD11b Gr-1 
bone marrow cells through an unknown mechanism. In
contrast, deficiency in Bak and Bim mice completely re-
stored the CD11b Gr-1  population in Bim /  mice to the
levels found in WT mice. These data suggest that the func-
tional redundancy displayed by Bak and Bax is cell type–spe-
cific. Moreover, loss of Bim negatively affects developing
myeloid cells, but the combined loss of Bax and Bim para-
doxically suppresses myeloid progenitor potential (unpub-
lished data). Thus, in bone marrow, Bax, Bak, or Bim may
function to promote the survival or differentiation of mye-
loid cells (52, 53). Together, these data indicate that expres-
sion of Bax or Bak differentially influences various myeloid
cell fates in bone marrow of Bim /  mice.
In contrast to bone marrow, Bak/Bim DKO and Bax/
Bim DKO mice display a marked increase in circulating
monocytes and neutrophils as compared with WT, Bak / ,
and Bax /  mice. Additionally, the myeloid populations in
Bak/Bim DKO and Bax/Bim DKO mice resemble Bim / 
mice in peripheral blood. Although there is a decrease in the
numbers of F4/80  peritoneal cells in Bim /  mice as com-
pared with WT, Bax / , and Bax/Bim DKO mice, there is
a concomitant increase in lymphocytes in the peritoneum of
Bim /  and Bax/Bim DKO mice (unpublished data). These
data suggest that deficiency in Bim affects the ratio of macro-
phages/lymphocytes, at least in certain tissues. Similarly, in
liver and spleen, Bak/Bim DKO and Bax/Bim DKO mice
have normal numbers of tissue macrophages. These data sug-
gest that Bak, Bax, or Bim do not affect extravasation or re-
cruitment of monocytes into a subset of tissues. Thus, an in-
crease in the monocyte pool through a decrease in apoptosis
is not a prerequisite for abnormally elevated numbers of
macrophages in tissues. Because in Bak/Bax DKO and Bax/
Bim DKO mice there is a normal complement or reduction
in myeloid precursor cells, respectively, and because there is
no difference in the numbers of tissue or peritoneal macro-
phages, these data suggest that the increase in peripheral
blood monocytes in Bak/Bim DKO, Bax/Bim DKO, or
Bim /  mice may be due to enhanced lifespan in peripheral
blood. The abnormal increase in the number of monocytes
in peripheral blood of Bak/Bim DKO, Bax/Bim DKO, or
Bim /  mice may result in a negative feedback loop that re-
duces the number of myeloid cells in bone marrow.
Previous studies demonstrated that Bim, but not Bax, sin-
gle-gene KO mice have abnormally increased numbers of B
lymphocytes in spleen (17, 36). In Bax/Bim DKO mice, the
increased numbers of CD19  cells in bone marrow may be
due to enhanced B cell production in bone marrow or in-
creased survival of B cells within the marrow. Alternatively, it
is possible that increased numbers of B cells in peripheral
blood may recirculate into bone marrow. We did not observe
an increase in the B cell population in bone marrow of Bak/
Bim DKO or Bim /  mice. In contrast, combined deficiency
in Bak/Bim or Bax/Bim exert a greater effect on the number
of B cells compared with WT, Bax / , Bak / , and Bim / 
mice in peripheral blood. However, the B cell population in
Bak/Bim DKO and Bax/Bim DKO mice resemble Bim / 
mice. Collectively, these data suggest that the overlapping
role of Bak and Bax may be dependent on individual cell
types within a given tissue. Although not examined in this
study, because Bim is critical for deletion of autoreactive B
cells (32) and because mice lacking Bim develop systemic lu-
pus erythematosus–like disease (at least on a mixed C57BL/6  
129Sv genetic background; reference 36), it is possible that
Bak/Bim DKO or Bax/Bim DKO mice may develop au-
toimmune disease, even on an inbred C57BL/6 background.
Taken together, the increase in B cells observed in Bak/Bim
and Bax/Bim DKO mice is further evidence that Bim is cen-
tral for the maintenance of B cell homeostasis.JEM VOL. 201, June 20, 2005 1957
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Although Bim may activate Bak or Bax to regulate the
development of B cells and to maintain their homeostasis in
the periphery, Bim seems to act preferentially on Bax, but
not on Bak, in thymocytes. Defects in development of thy-
mocytes in Bim /  mice are not exacerbated by loss of Bax.
Bim /  mice and Bax/Bim DKO mice display fewer dou-
ble-positive thymocytes than WT animals. This decrease in
double-positive thymocytes may be attributed to enhanced
maturation of thymocytes, which leave the thymus at a faster
rate or it may be due to a negative feedback loop in the thy-
mus triggered by the abnormally increased numbers of T
cells in the periphery (54, 55). Conversely, mice lacking Bak
and Bim show a thymic profile comparable to WT mice.
Together, these data suggest that although the expression of
Bak and Bax overlap in the thymus, their functions are not
redundant in Bim /  mice. In the thymus, Bak may not be
activated by another BH3 protein or Bak is not sufficient to
proceed with the process of negative selection in the absence
of Bax and Bim. In contrast, to compensate for the loss of
Bak, mice lacking Bak and Bim may show increased activa-
tion of Bax, which may be responsible for the normal thy-
mic populations. In this situation, monomers of Bax or the
increased levels of unbound Bcl-2–like prosurvival proteins
may function to reduce the accelerated maturation observed
in Bim /  mice. However, the latter possibility seems to be
unlikely because overexpression of Bcl-2 in thymocytes in-
duces a phenotype that resembles that found in Bim /  mice
(56). It is still unclear why in the absence of Bim, Bax and
Bak seem to be inactivated, whereas in mice deficient for
Bak and Bim, Bax may be activated. One possibility may be
that in the thymus, Bak may function as a prosurvival pro-
tein, which previously was shown to occur in neurons (53).
Future studies are required to delineate the role of Bak and
Bax in the selection and maturation processes of thymocytes
in the absence of Bim.
The combined loss of Bak and Bax confers remarkable
resistance to apoptosis induced by intrinsic apoptotic stimuli
(26). This inhibition is sustained over time because thy-
mocytes or lymphocytes from Bak/Bax DKO mice do not
undergo cytokine withdrawal-induced death over a 4-d pe-
riod (14, 17). During apoptosis, Bax or Bak become acti-
vated by BH3 proteins; this has been postulated to occur
through a direct interaction between these two groups of
proapoptotic Bcl-2 family members or through BH3 pro-
tein–mediated sequestering of prosurvival Bcl-2–like pro-
teins (54). The activated Bax or Bak causes permeabilization
of the outer mitochondrial membrane (directly or indi-
rectly), where it oligomerizes into higher-order species; this
results in the release of cytochrome c into the cytosol (43).
Recent studies using KO mice provided insight into the
functional interactions between BH3-only proteins, multi-
BH domain proapoptotic Bcl-2 family members, and antiap-
optotic Bcl-2–like proteins. Unlike deficiency in Bax (41) or
in the BH3-only gene, Bik (40), deficiency in Bim is able to
rescue the defects observed in mice lacking Bcl-2 (39).
These data suggest that Bcl-2 does not function solely to
prevent the activation of Bax (but also must inactivate Bak
function). These data also suggest that one of the roles of
Bim may be to block the function of Bcl-2. Bcl-2/Bim
DKO lymphocytes treated with certain intrinsic apoptotic
stimuli (e.g., cytokine deprivation) undergo much less apop-
tosis than Bcl-2 /  cells.; the Bcl-2/Bim DKO lymphocytes
are as resistant to apoptotic stimuli as Bim /  lymphocytes
(39). However, because Bcl-2/Bim DKO and Bim /  cells
still undergo apoptosis in response to certain apoptotic stim-
uli, such as DNA damage (39), these data indicate that fac-
tors in addition to Bim and Bcl-2 can regulate lymphocyte
death (Fig. 5). In this scenario, other BH3-only proteins,
such as Puma or Noxa (47), may activate Bak or Bax or in-
hibit Bcl-2–like prosurvival proteins, such as Bcl-xL or Mcl-1
(Fig. 5). Because deficiency in Noxa alone or Noxa plus
Bax  failed to protect thymocytes against Xray irradiation
(49), these data indicate that Noxa may not cooperate with
Bax in this cell death pathway. Here we show that Bim acts
through Bak or Bax to induce thymocyte apoptosis induced
by cytokine deprivation or treatment with etoposide. We
show that thymocytes lacking Bak and Bim or Bax and Bim
display a marked reduction in apoptosis, although not a
complete inhibition as observed in thymocytes lacking Bak
and Bax. These data demonstrate that in cultured thy-
mocytes, Bak and Bax act redundantly in the apoptotic pro-
cess. Our data does not preclude the possibility that the lack
of Bak and Bim or Bax and Bim results in an increased level
of Bcl-2 antiapoptotic proteins (54), but we have not found
any evidence for this. Recent studies have shown that the
BH3 peptide from Bim or Puma bind with very high affinity
to all antiapoptotic Bcl-2–like proteins, whereas the BH3
domain regions from the other BH3-only proteins exhibited
Figure 5. Summary of the genetic interactions of Bcl-2 family 
members. Previous studies have shown that deficiency in Bim, but not 
Bax, is sufficient to rescue Bcl-2 /  mice. These data suggest that, in part, 
Bcl-2 may function to inhibit Bim. Bcl-2 also may function to prevent the 
formation of higher-order complexes of Bak and Bax or function to 
prevent the activation of Bak or Bax. Because Bim /  or Bcl-2/Bim DKO 
thymocytes undergo apoptosis in response to certain intrinsic apoptotic 
stimuli (e.g., DNA damage), these data suggest that additional pathways 
that are independent of Bim must exist. However, all of these intrinsic 
pathways require Bak and Bax for apoptosis.REQUIREMENT FOR BAK OR BAX AND BIM DURING DEVELOPMENT | Hutcheson et al. 1958
more selective binding (57, 58). This may indicate that Bim
and Puma activate Bak/Bax function indirectly through
binding and neutralization of prosurvival Bcl-2 family mem-
bers. Another recent study supports the possibility that Bim
may act directly on Bak/Bax. Bim BH3 peptide, but not the
Puma BH3 peptide, was sufficient to induce the conforma-
tional change, oligomerization, and activation of Bak and
Bax to permeabilize mitochondrial membranes (58). Thus,
future genetic studies (e.g., generation of mice lacking Bak,
Bax, Bcl-2, or Bim) are necessary to determine whether Bim
has an active role in apoptosis through activation of Bak or
Bax or functions to sequester Bcl-2–like proteins.
MATERIALS AND METHODS
Mice. Bim-deficient mice (produced by gene targeting in W9.5 129Sv ge-
netic background embryonic stem (ES) cells and originally kept on a mixed
C57BL/6   129sv background) were described previously (36), and were
backcrossed onto the C57BL/6 background for 13 generations. Bax-deficient
mice (produced by gene targeting in RW-4 129Sv genetic background ES
cells and originally kept on a mixed C57BL/6   129Sv background; refer-
ence 20), which were backcrossed for 12 generations, Bak-deficient mice
(produced by gene targeting in R1 129Sv genetic background ES cells and
originally kept on a mixed C57BL/6   129sv background), which were
backcrossed for 5 generations (17), and congenic control (C57BL/6, B6)
mice were purchased from the Jackson ImmunoResearch Laboratories.
Bak/Bim and Bax/Bim DKO mice on the C57BL/6 background were es-
tablished at Saint Louis University, whereas Bax/Bim DKO mice which
had more contribution of 129Sv background genes (Bax mutant mice back-
crossed to C57BL/6 only 6 times) were established at the Walter and Eliza
Hall Institute of Medical Research. The Animal Care and Use Committee
at Saint Louis University and the Walter and Eliza Hall Institute of Medical
Research approved all experiments on mice.
Immunophenotyping. Peripheral blood was isolated from 5–8-wk-old
mice by cardiac puncture after euthanasia. Single-cell suspensions of bone
marrow, peritoneal cells, spleen, and thymus also were isolated. Nonspecific
staining of cells with antibodies was prevented by incubation with anti-
CD16/32 (24G2) monoclonal antibody (BD Biosciences). Cells were stained
with fluorochrome-conjugated antibodies to CD45, CD11b, Gr-1, CD62L,
CD19, CD3, CD4, CD8 (BD Biosciences), and F4/80 (Caltag), or isotype
control antibodies for 30 min. For peripheral blood, red blood cells were
lysed and cells were fixed with BD FACS lysing solution (BD Biosciences) af-
ter incubation with antibodies. For single-cell populations, red blood cells
were lysed with PharmLyse (BD Biosciences) before incubation with anti-
bodies and were fixed in 1% paraformaldehyde after incubation with antibod-
ies. Data were acquired on a BD FACSCalibur (BD Biosciences) using
CELLQuest Software at the St. Louis University Core Flow Cytometry Fa-
cility. All analysis was performed using FlowJo software (Tree Star Inc.). Total
peripheral blood leukocyte numbers were determined on the automated he-
matology analyzer ABX Pentra 60, whereas cell numbers from single-cell sus-
pensions of hemopoietic organs were determined by using a hemocytometer.
Immunohistochemistry. After euthanasia, mouse tissues were isolated,
fixed in 10% neutral buffered formalin, embedded in paraffin, and sectioned.
To stain for F4/80 expression, antigens were retrieved using the Dako target
retrieval solution (DakoCytomation). After antigen retrieval, sections were
blocked in hydrogen peroxide, incubated with anti-F4/80 (Caltag Laborato-
ries; Clone BM8 or CI:A3-1) antibody or an isotype-match control antibody
for 1 h, incubated with a secondary biotinylated rabbit anti–rat antibody (Da-
koCytomation), treated with streptavidin peroxidase conjugate (DakoCytoma-
tion), and the color was visualized with diaminobenzadine. All sections were
counterstained with hematoxylin. F4/80-positive cells were scored by examin-
ing three fields/section at 400  by an observer blinded to the study. A mini-
mum of 75 cells was counted in each field. Photographs were taken on a Ni-
kon microscope equipped with the Nikon digital camera DMX1200.
Cell culture. Thymocytes were isolated, counted, and plated in triplicate at
200,000 cells/well of a 48-well plate. Etoposide (7.5 ng/ml) or FasL (20 ng/
ml; Qbiogene) was added to thymocytes in culture. Cells were harvested at
24-h intervals; stained with Rh123, 7-AAD, and annexin V-APC; and ana-
lyzed by flow cytometry. Death by cytokine deprivation was triggered by
plating cells in 10% FBS/DMEM in the absence of added cytokines, and ana-
lyzing for apoptosis by flow cytometry every 24 h. To determine the activity
of caspase-3 and -9, 2   106 thymocytes/well were plated in a 6-well plate in
1 ml DMEM and treated with etoposide (7.5 ng/ml) or left untreated. Imme-
diately after processing, single-cell suspensions were collected (t   0). After
8 h, cells were harvested and analyzed for caspase-3 (BD Biosciences) and cas-
pase-9 (R&D Systems) activity as described by the manufacturer.
Statistical analysis. Results were expressed as the mean   standard error.
Differences between groups were analyzed using Student’s t test.
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